John Womelsdorf
Keine laufenden Positionen mehr
Profil
John Womelsdorf worked as Vice President-Business Development at Optimer Pharmaceuticals LLC and Cyclacel Pharmaceuticals, Inc. He holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree, and a doctorate from Stevens Institute of Technology.
Ehemalige bekannte Positionen von John Womelsdorf
| Unternehmen | Position | Ende |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 17.04.2009 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | - |
Ausbildung von John Womelsdorf
| Stevens Institute of Technology | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
